Fundraising September 15, 2024 – October 1, 2024 About fundraising

A biomarker-enriched, randomized Phase II trial of...

A biomarker-enriched, randomized Phase II trial of adavosertib (AZD1775) plus paclitaxel and carboplatin for women with platinum-sensitive TP53 -mutant ovarian cancer

Oza, Amit M, Estevez-Diz, Maria D P, Grischke, Eva-Maria, Hall, Marcia, Marmé, Frederik, Provencher, Diane M., Uyar, Denise S., Weberpals, Johanne I, Wenham, Robert M., Laing, Naomi, Tracy, Michael,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-20-0219
Date:
July, 2020
File:
PDF, 631 KB
2020
Conversion to is in progress
Conversion to is failed